AstraZeneca | Resultat Før Skatt

Pre Tax Profit Endring Dato
AbbVie USD 1.76B 4.24B 2024-03
Alcon AG USD 335M 65M 2024-03
Almirall EUR 15.1M 2.38M 2024-03
Amgen USD -68000000 3.09B 2024-03
AstraZeneca USD 2.8B 385M 2024-03
Bayer EUR 2.59B 1.42B 2024-03
Biogen USD 464.8M 336.9M 2024-03
Bristol-Myers Squibb USD -11516000000 15.59B 2024-03
Eli Lilly USD 2.54B 52.4M 2024-03
Fresenius EUR 414M 466M 2024-03
Fresenius Medical Care EUR 157.83M 77.17M 2024-03
Galapagos EUR 22.94M 84.96M 2024-03
Genmab DKK 1.72B 790M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
GlaxoSmithKline GBP 1.36B 549M 2024-03
GRIFOLS EUR 105.38M 115.62M 2023-12
Hikma Pharmaceutical USD 269M 18M 2022-12
Lonza CHF 508M 175M 2023-06
Merck EUR 899M 331.2M 2024-03
Merck USD 5.67B 6.14B 2024-03
Novartis USD 3.13B 606M 2024-03
Orion EUR 54.9M 37.5M 2024-03
Pfizer USD 3.42B 4.67B 2024-03
Philips EUR -894000000 1.43B 2024-03
Recordati EUR 161.15M 60.32M 2024-03
Regeneron Pharmaceuticals USD 700.7M 698.9M 2024-03
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 1.35B 2.61B 2024-03



AstraZeneca Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.